Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

Mutations

Mutations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>MiR-155</i>-targeted IcosL controls tumor rejection.

Proceedings of the National Academy of Sciences of the United States of America·2024

Same author

Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia.

Proceedings of the National Academy of Sciences of the United States of America·2023

Same author

PDCD1 (PD-1) is a direct target of miR-15a-5p and miR-16-5p.

Signal transduction and targeted therapy·2022

Same author

Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia.

Proceedings of the National Academy of Sciences of the United States of America·2020

Same author

Abrogation of esophageal carcinoma development in miR-31 knockout rats.

Proceedings of the National Academy of Sciences of the United States of America·2020

Same author

Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia.

Proceedings of the National Academy of Sciences of the United States of America·2019

Search research articles

Related Experiment Video

Updated: May 30, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

IRF4 mutations in chronic lymphocytic leukemia.

Violaine Havelange¹, Yuri Pekarsky, Tatsuya Nakamura

¹Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

|July 28, 2011

Summary

A new study found a specific mutation in the Interferon Regulatory Factor 4 (IRF4) gene in chronic lymphocytic leukemia (CLL) patients. This IRF4 mutation is associated with a good prognosis and higher IRF4 mRNA expression.

More Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

Related Experiment Videos

Last Updated: May 30, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

Area of Science:

Immunology
Genetics
Oncology

Background:

Interferon regulatory factor 4 (IRF4) plays a crucial role in B-cell development.
A polymorphism in the IRF4 gene's 3' untranslated region was previously linked to chronic lymphocytic leukemia (CLL) risk.

Purpose of the Study:

To investigate the role of IRF4 mutations in chronic lymphocytic leukemia (CLL).
To determine the clinical significance and prognostic value of IRF4 mutations in CLL patients.

Main Methods:

Somatic mutation analysis was performed on DNA from 457 CLL patients.
IRF4 mRNA expression levels were measured.
Clinical data and prognosis were analyzed in relation to IRF4 mutation status.

Main Results:

A recurrent heterozygous somatic mutation in the DNA-binding domain of IRF4 was identified in 1.5% (7/457) of CLL patients.
Patients with IRF4 mutations showed a good prognosis.
Four out of six patients with IRF4 mutations also exhibited trisomy 12.
IRF4 mRNA expression was elevated in patients harboring IRF4 mutations.

Conclusions:

Somatic mutations in the IRF4 DNA-binding domain are present in a subset of CLL patients.
IRF4 mutations in CLL are associated with a favorable prognosis and may be linked to trisomy 12.
Increased IRF4 mRNA expression is observed in CLL patients with these mutations.